References
- Ahmed I, Wahid Z, Nasreen S. Adverse effects of systemic isotretinoin therapy: a study of 78 patients. J Pak Assoc Dermatol. 2016;15:242–246.
- Gieler U, Gieler T, Kupfer J. Acne and quality of life–impact and management. J Eur Acad Dermatol Venereol. 2015; 29:12–14.
- Ingram JR, Grindlay D, Williams H. Management of acne vulgaris: an evidence‐based update. Clin Exp Dermatol. 2010;35:351–354.
- Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49:S1–S37.
- Huoh KC, Chang KW. Lip abscess associated with isotretinoin treatment of acne vulgaris. JAMA Dermatol. 2013;149: 960–961.
- Tahir CM. Efficacy and adverse effects of systemic isotretinoin therapy. J Pak Assoc Dermatol. 2016;21:38–42.
- Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: why not as first-line therapy? Facts and controversies. Clin Dermatol. 2010;28:24–30.
- Lowenstein EB, Lowenstein EJ. Isotretinoin systemic therapy and the shadow cast upon dermatology’s downtrodden hero. Clin Dermatol. 2011;29:652–656.
- Kus S, Gün D, Demirçay Z, et al. Vitamin E does not reduce the side‐effects of isotretinoin in the treatment of acne vulgaris. Int J Dermatol. 2005;44:248–251.
- Kobayashi H, Tagami H. Functional properties of the surface of the vermilion border of the lips are distinct from those of the facial skin. Br J Dermatol. 2004;150:563–567.
- Rademaker M. Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol. 2010;51:248–253.
- Ornelas J, Rosamilia L, Larsen L, et al. Objective assessment of isotretinoin-associated cheilitis: isotretinoin cheilitis grading scale. J Dermatol Treat. 2016;27:153–155.
- Cunliffe W. Mucocutaneous side-effects of isotretinoin and their management. Clin Dermatol. 2009;25:39–45.
- Park KY, Ko EJ, Kim IS, et al. The effect of evening primrose oil for the prevention of xerotic cheilitis in acne patients being treated with isotretinoin: a pilot study. Ann Dermatol. 2014;26:706–712.
- Fabbrocini G, Cameli N, Lorenzi S, et al. A dietary supplement to reduce side effects of oral isotretinoin therapy in acne patients. G Ital Dermatol Venereol. 2014;149:441–445.
- Cassano N, De Benedittis M, Petruzzi M, et al. Topical Vitamin E acetate for the treatment of cheilitis: a multicentre experience. Eur J Inflamm. 2003;1:125–128.
- Goforoushan F, Azimi H, Goldust M. Efficacy of vitamin E to prevent dermal complications of isotretinoin. Pak J Biol Sci. 2013;16:548–550.
- Madke B, Shah H, Singh AL, et al. Oral retinoid-induced cheilitis. Indian J Drugs Dermatol. 2016;2:50.
- Hong S-P, Han S-S, Choi S-J, et al. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. J Cosmet Laser Ther. 2012;14:81–86.
- Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76:447.
- Zayed A, Sobhi RM, Abdel Halim DM. Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatol Treat. 2014;25:223–225.
- Sezer E, Erbil H, Kurumlu Z, et al. A comparative study of focal medium-depth chemical peel versus cryosurgery for the treatment of solar lentigo. Eur J Dermatol. 2007;17: 26–29.
- Patel RV, Yanofsky VR, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012;5:25–36.
- Lee JB, Chung WG, Kwahck H, et al. Focal treatment of acne scars with trichloroacetic acid: chemical reconstruction of skin scars method. Dermatol Surg. 2002;28:1017–1021.